Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prognosis

  • Open Access
    CYBA as a Potential Biomarker for Renal Cell Carcinoma: Evidence from an Integrated Genetic Analysis
    CHI-FEN CHANG, SHU-PIN HUANG, YU-MEI HSUEH, PEI-LING CHEN, CHENG-HSUEH LEE, JIUN-HUNG GENG, CHAO-YUAN HUANG and BO-YING BAO
    Cancer Genomics & Proteomics September 2023, 20 (5) 469-475; DOI: https://doi.org/10.21873/cgp.20398
  • Open Access
    Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma
    VLASTIMIL KULDA, JIRI POLIVKA, MARTIN SVATON, TOMAS VANECEK, MARCELA BURESOVA, KATERINA HOUFKOVA, MAHYAR SHARIF BAGHERI, TEREZA KNIZKOVA, BOHUSLAVA VANKOVA, JINDRA WINDRICHOVA, PETR MACAN, VACLAV BABUSKA and MARTIN PESTA
    Cancer Genomics & Proteomics July 2023, 20 (4) 404-411; DOI: https://doi.org/10.21873/cgp.20392
  • Open Access
    Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study
    YOON AH CHO, SUNG-EUN KIM, CHEOL KEUN PARK, HYUN HEE KOH, CHEOL-KEUN PARK and SANG YUN HA
    Cancer Genomics & Proteomics May 2023, 20 (3) 298-307; DOI: https://doi.org/10.21873/cgp.20382
  • Open Access
    Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
    AKINORI MINATO, YUZAN KUDO, HIROTSUGU NOGUCHI, SHIRO KOHI, YOSHITAKA HASEGAWA, NORIHIRO SATO, KEIJI HIRATA and NAOHIRO FUJIMOTO
    Cancer Genomics & Proteomics March 2023, 20 (2) 203-210; DOI: https://doi.org/10.21873/cgp.20375
  • Open Access
    TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
    GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO
    Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
  • Open Access
    Identification of a Novel Long Non-coding RNA, lnc-ATMIN-4:2, and its Clinicopathological and Prognostic Significance in Advanced Gastric Cancer
    EOJIN KIM, HYUNJIN KIM, MIN-KYUNG YEO, CHUL HWAN KIM, JOO YOUNG KIM, SUNGSOO PARK, HYUN-SOO KIM and YANG-SEOK CHAE
    Cancer Genomics & Proteomics November 2022, 19 (6) 761-772; DOI: https://doi.org/10.21873/cgp.20358
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 489
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire